A novel microRNA-132-sirtuin-1 axis underlies aberrant B-cell cytokine regulation in patients with relapsing-remitting multiple sclerosis [corrected].
about
Is It worth Considering Circulating microRNAs in Multiple Sclerosis?Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple SclerosisDysregulated miR-34a-SIRT1-acetyl p65 axis is a potential mediator of immune activation in the colon during chronic simian immunodeficiency virus infection of rhesus macaques.Seeking balance: Potentiation and inhibition of multiple sclerosis autoimmune responses by IL-6 and IL-10.Natalizumab Therapy Modulates miR-155, miR-26a and Proinflammatory Cytokine Expression in MS Patients.Activation of human B cells negatively regulates TGF-β1 production.Antibody-independent functions of B cells: a focus on cytokines.B cells and their cytokine activities implications in human diseases.Cytokine-producing B cells: a translational view on their roles in human and mouse autoimmune diseases.Influence of the Gut Microbiome on Autoimmunity in the Central Nervous System.B Cell-Directed Therapeutics in Multiple Sclerosis: Rationale and Clinical Evidence.Epigenetic Modifications and Therapy in Multiple Sclerosis.Antibody-Independent Function of Human B Cells Contributes to Antifungal T Cell Responses.Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy.microRNA-132/212 deficiency enhances Aβ production and senile plaque deposition in Alzheimer's disease triple transgenic mice.Advances in Roles of miR-132 in the Nervous System.Deciphering the Role of B Cells in Multiple Sclerosis-Towards Specific Targeting of Pathogenic Function.Inverse correlation of expression of microRNA-140-5p with progression of multiple sclerosis and differentiation of encephalitogenic T helper type 1 cells.[MiRNAs: new actors in the physiopathology of multiple sclerosis].SIRT1, miR-132 and miR-212 link human longevity to Alzheimer's Disease.
P2860
Q26752505-AC31F633-2B37-4E33-9BE6-97384A93CF1EQ26771459-01AA12AD-FEDA-40EB-82EE-62B6752BB7B7Q34749385-B7B9EA6C-EEB0-4665-A948-D09514F0A18EQ35625089-9D1016B9-21FD-4251-ABE7-B5143884F042Q36054501-4559151E-4FC6-4D53-BEC5-289E432C0C6DQ37593519-4641DDD4-5FF5-4268-B46B-486594112970Q38525103-D421C63D-64DB-4FF5-944F-0B3195E390CFQ38665740-B15B2933-F437-4BE0-975E-D88D734FCD71Q38673420-F9819360-295C-427E-8217-58BDFE3D858DQ38772593-21334047-15D8-4E37-9E9C-1C05190378E3Q38795434-3D7B2775-5219-44D7-AE7A-0302DBD10E43Q38887611-CBCE0E7D-A276-42C1-83DB-A492DAFE7720Q40302214-37FAF75C-8070-463B-9941-7DC3E89764B0Q40404169-5C15E83B-D318-4E20-9E89-6CD558D5CD03Q42384091-969CEB90-C045-4298-A478-4B36A5B2608FQ43155689-461B750E-7BEB-41B8-9A3F-059F7BEEA024Q47102132-0DC0CA75-60AA-40AB-AF37-D22CC46F426BQ48066089-8F12308C-246F-4B2E-8979-34901FC022E8Q49485817-001B2A5A-41F1-4B22-89F2-A5AB57185B0BQ54958137-08B75B98-22F9-4950-9249-CCBF2CEB2CC6
P2860
A novel microRNA-132-sirtuin-1 axis underlies aberrant B-cell cytokine regulation in patients with relapsing-remitting multiple sclerosis [corrected].
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A novel microRNA-132-sirtuin-1 ...... ultiple sclerosis [corrected].
@ast
A novel microRNA-132-sirtuin-1 ...... ultiple sclerosis [corrected].
@en
A novel microRNA-132-sirtuin-1 ...... ultiple sclerosis [corrected].
@nl
type
label
A novel microRNA-132-sirtuin-1 ...... ultiple sclerosis [corrected].
@ast
A novel microRNA-132-sirtuin-1 ...... ultiple sclerosis [corrected].
@en
A novel microRNA-132-sirtuin-1 ...... ultiple sclerosis [corrected].
@nl
prefLabel
A novel microRNA-132-sirtuin-1 ...... ultiple sclerosis [corrected].
@ast
A novel microRNA-132-sirtuin-1 ...... ultiple sclerosis [corrected].
@en
A novel microRNA-132-sirtuin-1 ...... ultiple sclerosis [corrected].
@nl
P2093
P2860
P50
P921
P1433
P1476
A novel microRNA-132-sirtuin-1 ...... ultiple sclerosis [corrected].
@en
P2093
Ajit Singh Dhaunchak
Alexandre Prat
Amit Bar-Or
Ayman Rezk
CIHR/MSSC New Emerging Team Grant in Clinical Autoimmunity
Craig Moore
David Colman
Hétoum Misirliyan
Jack Antel
Lorna Galleguillos Goiry
P2860
P304
P356
10.1371/JOURNAL.PONE.0105421
P407
P577
2014-08-19T00:00:00Z